Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals

Aiello, Tommaso FrancescoPuerta-Alcalde, PedroChumbita, MarianaLopera, CarlosMonzó Gallo, PatriciaCortes, AlbertFernández Avilés, FrancescSuárez Lledó, MaríaCorrea, JuanOrtiz-Maldonado Gibson, ValentínCuesta, GenovevaMartínez Cibrian, Nuria.Esteve Reyner, JordiMarcos, María ÁngelesMensa, JosepSoriano Viladomiu, AlexGarcia Vidal, Carolina2024-01-242024-04-132023-04-131460-2091https://hdl.handle.net/2445/20627117 p.application/pdfeng(c) Oxford University Press, 2023Medicaments antivíricsMedicaments dermatològicsAntiviral agentsDermatologic agentsCurrent outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antiviralsinfo:eu-repo/semantics/article2024-01-18info:eu-repo/semantics/openAccess934994637051877